SCHEMBL4187133

SCHEMBL4187133

CN[C@@H](C)C(=O)NS(=O)(=O)c1ccc(OC)c(OC)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.52
FLT1 P17948 1/20 0.52
FLT4 P35916 1/20 0.52
KDR P35968 1/20 0.52
LMNA P02545 1/20 0.51
HTT P42858 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
MEN1 O00255 4/20 0.50
CA12 O43570 1/20 0.49
CA9 Q16790 1/20 0.49
POLB P06746 1/20 0.49
TSHR P16473 1/20 0.49
MAPK1 P28482 1/20 0.49
FFAR4 Q5NUL3 1/20 0.48
PDE4A P27815 1/20 0.47
PDE4B Q07343 1/20 0.47
PDE4C Q08493 1/20 0.47
PDE4D Q08499 1/20 0.47
KEAP1 Q14145 1/20 0.47
NFE2L2 Q16236 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26041452 0.83 FLT1 (0.54) KMT2AFLT1FLT4KDRLMNA
SCHEMBL4184408 0.77 KMT2A (0.58) KMT2ALMNAHTTSMN1; SMN2MEN1
SCHEMBL4184412 0.77 KMT2A (0.58) KMT2ALMNAHTTSMN1; SMN2MEN1
SCHEMBL4608475 0.75 LMNA (0.67) KMT2ALMNAHTTSMN1; SMN2MEN1
SCHEMBL26041431 0.74 CYP2C9 (0.56) KMT2AFLT1FLT4KDRLMNA
SCHEMBL24040870 0.74 ALDH1A1 (0.74) KMT2ALMNAHTTSMN1; SMN2CA12
SCHEMBL4180372 0.74 KMT2A (0.61) KMT2ALMNAHTTSMN1; SMN2MEN1
SCHEMBL10414317 0.74 TSHR (0.50) KMT2ALMNAHTTSMN1; SMN2MEN1
Hydrochloric Acid SCHEMBL4609744 0.74 LMNA (0.65) KMT2ALMNAHTTSMN1; SMN2MEN1
SCHEMBL15880603 0.74 CA1 (0.73) KMT2ALMNAHTTSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090069302-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069302-A1 CHEMICAL COMPOUNDS TBXA2R, PDE4D, PDE4A KMT2A 3729/4885FLT1 2819/4885FLT4 2740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.